Repligen reported $182.2M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Agilent USD 1.12B 28M Jun/2026
Align Technology USD 212.24M 2.7M Jun/2026
Bio Techne USD 197.67M 1.92M Sep/2026
BioMarin Pharmaceutical USD 1.8B 13.54M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Bruker USD 1.12B 1.4M Jun/2026
Charles River Laboratories USD 319.64M 26.62M Sep/2026
Danaher USD 3.13B 126M Sep/2026
Dentsply International USD 707M 42M Sep/2026
General Electric Aerospace USD 12.74B 303M Sep/2026
Henry Schein USD 2.05B 9M Sep/2026
Illumina USD 667M 38M Sep/2026
Mettler Toledo International USD 439.66M 28.1M Sep/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
OraSure Technologies USD 30.07M 236K Jun/2026
Pacific Biosciences Of California USD 60.28M 806K Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Repligen USD 182.2M 4.4M Sep/2026
Revvity USD 388.85M 10.35M Sep/2026
Standard Biotools USD 17.62M 514K Sep/2026
Thermo Fisher Scientific USD 5.64B 16M Sep/2026
Waters USD 1.32B 53M Sep/2026
West Pharmaceutical Services USD 464.7M 17.3M Sep/2026